Target intelligence / Profile preview

NACA pseudogene 10 (NACAP10)

Target
NACAP10
Molecular classification
Other (Pseudogene)
01

Overview

NACA pseudogene 10 (NACAP10), also known as nascent polypeptide-associated complex alpha subunit 2 pseudogene, is annotated as a pseudogene in the human genome, mapped to chromosome 8 (chr8:67569416-67570078, hg38)[2][3]. Pseudogenes are genomic sequences related to protein-coding genes but do not encode functional proteins due to disabling mutations or lack of necessary regulatory elements[6]. NACAP10 is annotated in major genomic resources (e.g., NCBI Gene: 100132812, Ensembl: ENSG00000254253)[2][3], and is derived from or related to the parental gene NACA (nascent polypeptide-associated complex subunit alpha)[4]. There is no evidence for translated protein, disease associations, or utility as a therapeutic target, biomarker, or drug-interacting molecule. While some pseudogenes have been shown to regulate gene expression through non-coding RNA mechanisms in other gene families (e.g., through microRNA sponging or competitive endogenous RNA activity)[6], there is no such documented activity for NACAP10. Thus, NACAP10 is best classified as a noncoding genomic element with no known protein product or direct role in human health or disease[2][3][4].

Other names
nascent polypeptide-associated complex alpha subunit 2 pseudogene
02

Biological functions

Other (No established protein coding function; pseudogene)
03

Disease associations

Other (No direct disease association; as a pseudogene, may theoretically regulate parental gene expression via noncoding RNA mechanisms, but no disease or biomarker implication is described for NACAP10 specifically[2][3])

Beyond the preview

Go deeper on NACA pseudogene 10 (NACAP10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NACA pseudogene 10 (NACAP10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call